Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNK-FLOW: Intra-Arterial Tenecteplase Post-Thrombectomy for LVO Stroke
NCT06781385Phase 2Enrolling by invitation
- Sponsor
- Wake Forest University Health Sciences
- Start
- Sep 2025
- Primary completion
- Jun 2028
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tenecteplase in ischemic stroke, sponsored by Wake Forest University Health Sciences. Started Sep 2025; status: enrolling by invitation.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06781385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06781385.